Nasdaq · Healthcare
Bon Natural Life Ltd (BON)
As-reported financials and recent SEC filings for Bon Natural Life Ltd, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$18.7M
Net income
$-2.0M
Net margin
-10.7%
Diluted EPS
$-0.72
ROE
-3.4%
P/E (TTM)
—
Market cap
—
Debt / equity
0.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $18.7M | $23.8M | $29.5M | $29.9M | $25.5M |
| Gross profit | $3.9M | $7.1M | $8.8M | $9.4M | $7.1M |
| Operating income | $-1.6M | $1.9M | $5.9M | $6.6M | $5.4M |
| Net income | $-2.0M | $398,172 | $4.6M | $6.2M | $4.6M |
| Diluted EPS | $-0.72 | $0.14 | $1.44 | $1.96 | $1.44 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
32026-05-15
View on EDGAR →32026-04-23
View on EDGAR →32026-04-10
View on EDGAR →32026-04-10
View on EDGAR →32026-04-10
View on EDGAR →32026-04-10
View on EDGAR →32026-04-10
View on EDGAR →32026-04-10
View on EDGAR →Largest Healthcare peers
Go deeper on BON
Search Bon Natural Life Ltd’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.